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Asthma

Courtney Schweickart, RN, BSN, CCRN
Otterbein University, Westerville, Ohio
Introduction to
Asthma
A chronic inflammatory airway
disorder, asthma is marked by
airway hyper- responsiveness
with recurrent episodes of
wheezing, coughing, tightness of
the chest, and shortness of
breath. Typically, these episodes
are associated with airflow
obstruction that may be reversed
spontaneously or with treatment”
(Lynn & Kushto-Reese, 2015).
Asthma is an extremely common
diagnosis seen in the Pediatric
Intensive Care Unit at
Nationwide Children’s Hospital.
While most asthmatic patients
can be well controlled with
proper management,
exacerbations in the intensive
care setting can be life
threatening. Some of these
exacerbations can be attributed
to exposure to antigens, noncompliance to treatment, or
respiratory infections (bacterial
or viral) just to name a few. I
chose this topic due to my
familiarity with the asthmatic
patient population, as well as the
vast spectrum of illness
asthmatic patients can
experience. It is not uncommon
on our unit to have an asthmatic
patient intubated, with multiple
bronchodilators/vasoactive
medications infusing, yet down
the hall to have an asthmatic
eating lunch while on continuous
albuterol. I hope to break down
the pathophysiology of an
asthma diagnosis, treatment, and
management as well as show the
progression of how truly ill the
asthmatic population can become
in the acute intensive setting.

Signs and Symptoms
“The most common signs
of asthma are coughing,
especially at night, during
exercise or when laughing,
difficulty breathing, chest
tightness, shortness of breath,
and wheezing (a whistling or
squeaky sound in your chest
when breathing, especially
when exhaling)”(American
College of Allergy, Asthma,
& Immunology).
“Asthma is an obstructive
pulmonary disorder with
exacerbations characterized
by symptoms of shortness of
breath, cough, chest tightness,
and/or wheezing. Symptoms
are caused by chronic airway
inflammation” (Maslan &
Mims 2014).

Asthma signs and symptoms
include:
•Shortness of breath
•Chest tightness
•Trouble sleeping throughout the
night
•A whistling or wheezing sound
when exhaling (wheezing).
•Coughing that is worsened by a
respiratory viruses, or flu-like
illnesses.
Signs that your asthma is
probably worsening include:
•Any of the above symptoms
becoming more frequent and
bothersome
•The need to use a quick-relief
inhaler more often
One should recognize when
appropriate to seek the aid of
advanced medical professionals.

The Pathophysiology of Asthma and its
Significance
“Asthma is an obstructive pulmonary disorder with exacerbations
characterized by symptoms of shortness of breath, cough, chest
tightness, and/or wheezing. Symptoms are caused by chronic
airway inflammation. There are multiple cell types and
inflammatory mediators involved in its pathophysiology. The
airway inflammation is frequently mediated by Th2 lymphocytes,
whose cytokine secretion leads to mast cell stimulation,
eosinophilia, leukocytosis, and enhanced B-cell IgE production.
Although various genes have been identified as likely contributors
to asthma development, asthma is largely environmentally
triggered and has a multifactorial cause. Asthma is extremely
common, especially in poor, urban environments. Asthma is the
third most common reason for pediatric hospitalizations” (Maslan
& Mims 2014). As mentioned above, the pathophysiology of
asthma is multifaceted. “Asthma can affect the trachea, the bronchi
and the bronchioles, which form part of the lower respiratory tract.
The disease causes bronchoconstriction or abnormal narrowing of
the airways as a result of epithelial damage, over-production of
mucus, edema, bronchospasm and muscle damage” (Barnes 1996,
Rees 2010). “In asthma, the epithelium (the layer of cells that line
the airways) can become damaged and peel away. Epithelial
shedding can contribute to airway hyper-responsiveness in several
ways; these include loss of barrier function, which may allow
penetration of allergens; loss of enzymes that break down
inflammatory mediators; and exposure of sensory nerves, which
may lead to reflex neural effects on the airway” (Barnes 1996).
“Asthma causes the mucus-secreting cells in the airways to
multiply and the mucous glands to expand. Increased mucus
secretion contributes to the formation of viscid mucous plugs that
can occlude the airways” (Ward et al 2010). “The capillaries in the
airway walls can dilate and may leak. The consequences of
microvascular leakage include increased airway secretions,
impaired mucociliary clearance and edema, which may contribute
to airway narrowing and hyper-responsiveness” (Barnes 1996).
Bronchospasm, or a bronchial spasm is a sudden constriction of
the muscles in the walls of the bronchioles. It is caused by the
release (degranulation) of substances from mast cells or basophils
under the influence of anaphylatoxins. It causes difficulty in
breathing which can be very mild to severe. “With poorly
controlled or undertreated asthma, changes in structural cells and
tissues can occur in the lower respiratory tract that lead to
remodeling of the airway, resulting in permanent fibrotic damage”
(Rees 2010).

References
Implications for Nursing Care
Nursing implications in regards to asthma include
medication management, a well-controlled regiment, and
eliminating triggers that cause asthma symptoms.
Controller medications should be taken daily, and include
inhaled corticosteroids (Qvar/ Flovent). “Leukotriene
receptor antagonists, such as montelukast and zafirlukast,
affect the production and/or activity of leukotrienes, which
are responsible for airway inflammation and hyperresponsiveness, mucus production, edema and
bronchoconstriction” (Kaufman 2011). These medications
should also be taken every day. Short acting beta-agonists
provide quick relief during an asthma exacerbation and are
used to quickly relax the airways, and open up the patient’s
airways. One should not be using their rescue inhaler more
than twice a week, if that is the case one should see their
allergist, or pulmonologist. Oral Steroids can be used in the
acute phase of an illness or exacerbation as well but should
not be utilized long term due to the side effects of
prolonged oral steroid usage. Avoiding environmental
triggers, as well as known allergy causing agents is
important in the management of one’s asthma. As long as
the patient as well as the patient’s family are aware of such
triggers, hopefully the road of management that lies ahead
is one with promise.

Conclusion
“A thorough clinical history and objective measurement of
lung function are important in establishing a reasonably
certain diagnosis of asthma. A range of drugs is used in the
management of the disease, and clinical guidelines advocate
a stepwise approach to drug therapy, where treatment is
stepped up when required and stepped down when control is
good. Alongside pharmacological management of the
disease, partnership working between patients and healthcare
professionals, personalized written asthma action plans,
information and education are central to improving the
quality of life of patients with asthma” (Kaufman 2011).
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